NDC 68875-0101

Gattex

Teduglutide

Gattex is a Subcutaneous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Shire-nps Pharmaceuticals, Inc.. The primary component is Teduglutide.

Product ID68875-0101_008b6d52-ee4e-466e-a4be-8f3ce9b4bdcb
NDC68875-0101
Product TypeHuman Prescription Drug
Proprietary NameGattex
Generic NameTeduglutide
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2012-12-21
Marketing CategoryNDA / NDA
Application NumberNDA203441
Labeler NameShire-NPS Pharmaceuticals, Inc.
Substance NameTEDUGLUTIDE
Active Ingredient Strength5 mg/.5mL
Pharm ClassesGLP-2 Analog [EPC],Glucagon-like Peptide-2 (GLP-2) Agonists [MoA],Glucagon-Like Peptide 2 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 68875-0101-2

30 VIAL in 1 CARTON (68875-0101-2) > .5 mL in 1 VIAL (68875-0101-1)
Marketing Start Date2012-12-21
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68875-0101-4 [68875010104]

Gattex INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA203441
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-12-21
Marketing End Date2013-01-16

NDC 68875-0101-1 [68875010101]

Gattex INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA203441
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-01-16

NDC 68875-0101-2 [68875010102]

Gattex INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA203441
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-12-21

Drug Details

Active Ingredients

IngredientStrength
TEDUGLUTIDE5 mg/.5mL

OpenFDA Data

SPL SET ID:66b69c1e-b25c-44d3-b5ff-1c1de9a516fa
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1489307
  • 1364472
  • 1364477
  • PHarm Class EPC
  • GLP-2 Analog [EPC]
  • NUI Code
  • N0000175140
  • N0000175452
  • N0000190990
  • N0000190992
  • Pharmacological Class

    • GLP-2 Analog [EPC]
    • Glucagon-like Peptide-2 (GLP-2) Agonists [MoA]
    • Glucagon-Like Peptide 2 [Chemical/Ingredient]
    • Analogs/Derivatives [Chemical/Ingredient]

    NDC Crossover Matching brand name "Gattex" or generic name "Teduglutide"

    NDCBrand NameGeneric Name
    68875-0101Gattexteduglutide
    68875-0102Gattexteduglutide
    68875-0103Gattexteduglutide

    Trademark Results [Gattex]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    GATTEX
    GATTEX
    85731454 4475896 Live/Registered
    SHIRE-NPS PHARMACEUTICALS, INC.
    2012-09-18
    GATTEX
    GATTEX
    78333286 3406472 Live/Registered
    SHIRE-NPS PHARMACEUTICALS, INC.
    2003-11-25

    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.